Discover the Latest in Biomedical Research Innovation

Run an ANCOVA and a multiple regression on the same data, specified equivalently, and you get the same F, the same p, and the same coefficients. They are one model with two traditions, and dummy coding is the bridge. So the real question isn't which is correct but which framing makes your result clearest. This piece covers why they're equivalent, what genuinely differs, and how to describe your model so reviewers from either tradition can follow it.

Hunted through Prism's Analyze menu for ANCOVA? It isn't there, and GraphPad's own FAQ confirms they've never shipped one. Prism can still do it, through two documented routes most users never find: the simple-linear-regression slopes test for the parallel-slopes assumption, and multiple regression with dummy-coded groups for the adjusted comparison. Here are both step by step, plus an honest comparison with describing the same analysis in plain language instead.

Most bench scientists reach for a t-test or ANOVA by reflex, but plenty of real experiments have a continuous dose, groups that differ at baseline, or nuisance variation eating the power. Multiple regression handles all three, and ANOVA and ANCOVA turn out to be special cases of it. This guide covers when regression earns its place, how to read coefficients honestly, the two covariate mistakes that invalidate an analysis, and why dose-response needs a 4PL curve, not a line.

When medical residents were surveyed on interpreting a p-value, 88% were confident they understood it and 100% got it wrong. That gap is why p-value mistakes survive peer review: nobody thinks they're making one. This piece covers the five most common errors in biomedical papers, several measured at scale in real journals: the inverse probability fallacy, the replication fallacy, 'trending toward significance', p-hacking, and treating 0.05 as a bright line.

A small p-value tells you a difference is probably real, not that it's big enough to matter. Statistical significance asks whether an effect is distinguishable from noise; biological significance asks whether it's large enough to change a cell, a patient, or a conclusion. Because the p-value shrinks as your sample grows, a big enough study can stamp p < 0.05 on a difference that means nothing. Here's why, with real examples, and what to report instead: effect size and confide

Are you still using the Student’s t-test for your biomedical data? Biological data rarely satisfies the "equal variance" assumption required by classical tests. This step-by-step guide explains why the Welch’s t-test is the superior, robust alternative for modern research. From calculating degrees of freedom to interpreting p-values in clinical contexts, we provide the ultimate protocol to ensure your statistical analysis is bulletproof and publication-ready.

Choosing between Welch's t-test, data transformation, and non-parametric tests like Mann-Whitney U is a critical decision that affects your p-values and publication chances. While standard t-tests often fail due to unequal variances, blindly switching to non-parametric tests can kill your statistical power. This guide simplifies the decision process, explaining why Welch's t-test should be your default and when to truly embrace ranking methods.